by Arjun Walia, Collective Evolution:
- The Facts:UCLA Professor David Cohen explains how there is zero evidence that antidepressant medications work in the long term and calls out the relationship between big pharma and big politics as a cause for the lack of long term studies.
- Reflect On:Why is there so much focus on medication as the only solution for depression when many studies show they are not only ineffective, but can also be harmful and dangerous. Why aren’t other holistic/natural alternatives explored?
TRUTH LIVES on at https://sgtreport.tv/
Below is a brief clip from of David Cohen, a professor and Associate Dean for Research and Development of at the Luskin School of Social Work, University of California, Los Angeles (UCLA). His research focuses on psychoactive drugs (prescribed, licit, and illicit) and their desirable and undesirable effects as socio-cultural phenomena “constructed” through language, policy, attitudes, and social interactions.
He has conducted research on the side effects of psychiatric medications and on withdrawal. Public and private institutions in the U.S., Canada, and France have funded him to conduct clinical-neuropsychological studies, qualitative investigations, and epidemiological surveys of patients, professionals, and the general population.
He has authored or co-authored over 100 book chapters and articles. Recent co-authored books include Your Drug May be Your Problem (1999/2007), Critical New Perspectives on ADHD (2006), and Mad Science (2013). He held the Fulbright-Tocqueville Chair to France in 2012.
In the clip, taken from the Medicating Normal documentary, he explains how antidepressants may provide a very short term mood boost for patients. He also expresses why pharmaceutical companies only conduct short-term studies instead of long term studies for antidepressant medications.
A study published in the Journal of Clinical Epidemiology looked at 185 meta-analyses on antidepressant medication and found that one third of them were written by pharmaceutical industry employees and that almost 80 percent of the studies had industry ties.
A study published in the British Medical Journal by researchers at the Nordic Cochrane Center in Copenhagen showed that pharmaceutical companies were not disclosing all information regarding the results of their drug trials. Researchers looked at documents from 70 different double-blind, placebo-controlled trials of selective serotonin reuptake inhibitors (SSRI) and serotonin and norepinephrine reuptake inhibitors (SNRI) and found that the full extent of serious harm in clinical study reports went unreported.
“We really don’t have good enough evidence that antidepressants are effective and we have increasing evidence that they can be can be harmful. So we need to go into reverse and stop this increasing trend of prescribing them.” – Joanna Moncrieff, a psychiatrist and researcher at University College London (source)
These medications don’t seem to be prescribed based on honest evidence when it comes to the cause of these illnesses, as well as what exactly these drugs are doing to our brain and biology. For example, A New England Journal of Medicine review on Major Depression is one of multiple that express these sentiments:
… numerous studies of norepinephrine and serotonin metabolites in plasma, urine, and cerebrospinal fluid as well as postmortem studies of the brains of patients with depression, have yet to identify the purported deficiency reliably.